Orbimed Advisors - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 166 filers reported holding BLUEBIRD BIO INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q4 2018$38,410,000
-42.7%
387,200
-15.7%
0.71%
-12.1%
Q3 2018$67,043,000
-12.5%
459,200
-5.9%
0.81%
-11.6%
Q2 2018$76,623,000
+29.8%
488,200
+41.3%
0.91%
+24.9%
Q1 2018$59,011,000
-13.7%
345,600
-10.0%
0.73%
-15.4%
Q4 2017$68,399,000
+3.3%
384,046
-20.3%
0.86%
+36.7%
Q3 2017$66,195,000
+57.6%
481,946
+20.5%
0.63%
+43.9%
Q2 2017$41,999,000
+62.8%
399,800
+40.9%
0.44%
+50.7%
Q1 2017$25,797,000
+47.3%
283,8000.0%0.29%
+30.9%
Q4 2016$17,510,000
-78.2%
283,800
-76.1%
0.22%
-75.6%
Q3 2016$80,374,000
+56.6%
1,185,8000.0%0.92%
+70.7%
Q2 2016$51,333,000
+27.7%
1,185,800
+25.4%
0.54%
+26.7%
Q1 2016$40,184,000
-33.6%
945,500
+0.4%
0.42%
-22.8%
Q4 2015$60,476,000
-40.5%
941,700
-20.8%
0.55%
-46.6%
Q3 2015$101,710,000
-37.0%
1,188,900
+24.1%
1.03%
-13.3%
Q2 2015$161,349,000
+142.6%
958,300
+74.0%
1.18%
+108.5%
Q1 2015$66,508,000
+912.0%
550,700
+90.6%
0.57%
+601.2%
Q1 2014$6,572,000
+9.6%
289,000
+29.9%
0.08%
-24.3%
Q3 2013$5,999,000222,5000.11%
Other shareholders
BLUEBIRD BIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,550,000$7,518,0001.50%
Birchview Capital, LP 84,000$407,0000.29%
PDT Partners, LLC 519,485$2,520,0000.22%
OCCUDO QUANTITATIVE STRATEGIES LP 320,922$1,556,0000.13%
Virtus ETF Advisers LLC 40,607$197,0000.09%
Baker Brothers Advisors 2,499,715$12,124,0000.07%
Green Alpha Advisors, LLC 14,660$71,0000.05%
Quinn Opportunity Partners LLC 140,824$683,0000.03%
Rafferty Asset Management, LLC 979,122$4,749,0000.03%
Inspire Investing, LLC 48,724$236,0000.03%
View complete list of BLUEBIRD BIO INC shareholders